Cathelicidins: Microbicidal activity, mechanisms of action, and roles in innate immunity

Microbes and Infection

Volumn 4, Issue 3, 2002, Pages 361-372

  Ramanathan, Balaji ^a   Davis, Elizabeth G ^a   Ross, Christopher R ^a   Blecha, Frank ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

Antimicrobial peptides; Cathelicidin; Innate immunity; Natural antibiotics

Indexed keywords

CATHELICIDIN; PROTEIN PRECURSOR;

ALPHA HELIX; AMINO ACID SEQUENCE; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ANTISEPSIS; BACTERICIDAL ACTIVITY; BETA CHAIN; DRUG MECHANISM; FUNGUS; GENE EXPRESSION; GENE SEQUENCE; GENE STRUCTURE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; VIRUS; WOUND HEALING;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; IMMUNITY, NATURAL; MODELS, GENETIC; PROTEIN PRECURSORS;

EID: 0036218636     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)01549-6     Document Type: Review

References (155)

1. Defensins: Antimicrobial and cytotoxic peptides of mammalian cells
2. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: Receptors and activities of human defensins and cathelicidin (LL-37)
3. Evolutionary diversification of the mammalian defensins
4. Expression of mammalian defensin genes
5. Structural features and biological activities of the cathelicidin- derived antimicrobial peptides
6. Structure and biology of cathelicidins
7. Cathelicidins: A novel protein family with a common proregion and a variable C-terminal antimicrobial domain
8. The cathelicidin family of antimicrobial peptide precursors: A component of the oxygen-independent defense mechanisms of neutrophils
9. The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics
10. Primary structure of a new cysteine proteinase inhibitor from pig leucocytes
11. A new type of low-molecular mass cysteine proteinase inhibitor from pig leukocytes
12. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis
13. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein
14. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules
15. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations
16. Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules
17. Novel cathelicidins in horse leukocytes
18. Biological characterization of a novel mammalian antimicrobial peptide
19. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils
20. Cloning and analysis of a transcript derived from two contiguous genes of the cathelicidin family
21. Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils
22. Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities
23. Structural organization of the bovine cathelicidin gene family and identification of a novel member
24. Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils
25. Amino acid sequences of two proline-rich bactenecins. Antimicrobial peptides of bovine neutrophils
26. cDNA cloning of the neutrophil bactericidal peptide indolicidin
27. cDNA sequence analysis of an antibiotic dodecapeptide from neutrophils
28. Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide
29. cDNA sequences of three sheep myeloid cathelicidins
30. Localization and genomic organization of sheep antimicrobial peptide genes
31. Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes
32. Molecular cloning of a putative homolog of proline/arginine-rich antibacterial peptides from porcine bone marrow
33. Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes
34. The structure of porcine protegrin genes
35. Identification of a new member of the protegrin family by cDNA cloning
36. cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39
37. A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence
38. Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA
39. Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells
40. PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity
41. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides
42. Protegrins: Leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins
43. Complementary DNA sequence of rabbit CAP18 - A unique lipopolysaccharide binding protein
44. A novel murine cathelin-like protein expressed in bone marrow
45. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse
46. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation
47. Structures of genes for two cathelin-associated antimicrobial peptides: Prophenin-2 and PR-39
48. Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: Comparative mapping of the locus for the human peptide antibiotic FALL-39
49. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes
50. Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides
51. Regulation of cathelicidin gene expression: Induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection
52. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules
53. Antimicrobial peptides of phagocytes and epithelia
54. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
55. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity
56. Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins
57. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils
58. Primary structure of three cationic peptides from porcine neutrophils. Sequence determination by the combined usage of electrospray ionization mass spectrometry and edman degradation
59. Molecular cloning of a novel myeloid granule protein
60. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa
61. Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus
62. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6
63. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator
64. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface
65. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients
66. Cathelicidin gene expression in porcine tissues: Roles in ontogeny and tissue specificity
67. Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides
68. Biochemical and antibacterial analysis of human wound and blister fluid
69. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins
70. Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins
71. The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids
72. Isolation of two isoforms of a novel 15-kDa protein from rabbit polymorphonuclear leukocytes that modulate the antibacterial actions of other leukocyte proteins
73. p15s (15-kD antimicrobial proteins) are stored in the secondary granules of rabbit granulocytes: Implications for antibacterial synergy with the bactericidal/permeability-increasing protein in inflammatory fluids
74. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma
75. Chemotactic and protease-inhibiting activities of antibiotic peptide precursors
76. Bactericidal activity of mammalian cathelicidin-derived peptides
77. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa
78. SMAP-29: A potent antibacterial and antifungal peptide from sheep leukocytes
79. CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity
80. Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity
81. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates
82. In vitro anti-cryptosporidial activity of cationic peptides alone and in combination with inhibitors of ion transport systems
83. In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii
84. Mode of action of the antimicrobial peptide indolicidin
85. Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity
86. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils
87. Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils
88. Antimicrobial activity of two bactenecins against spirochetes
89. Rapid membrane permeabilization and inhibition of vital functions of gram-negative bacteria by bactenecins
90. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine
91. In vitro activities of membrane-active peptides against gram-positive and gram-negative aerobic bacteria
92. Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils
93. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide
94. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane
95. Susceptibility of Neisseria gonorrhoeae to protegrins
96. Susceptibility of Chlamydia trachomatis to protegrins and defensins
97. Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides
98. Haemophilus ducreyi is susceptible to protegrin
99. Protegrin structure and activity against Neisseria gonorrhoeae
100. Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity
101. Antimicrobial peptides as agents of mucosal immunity
102. Peptides as weapons against microorganisms in the chemical defense system of vertebrates
103. Peptide antibiotics and their role in innate immunity
104. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: Relevance to the molecular basis for its non-cell-selective activity
105. Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids
106. Mechanism of antimicrobial action of indolicidin
107. In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis
108. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations
109. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes
110. Change in membrane permeability induced by protegrin 1: Implication of disulphide bridges for pore formation
111. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation
112. Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor
113. Cell-free immunity in cecropia. A model system for antibacterial proteins
114. Seminalplasmin is a potent inhibitor of E. Coli RNA polymerase in vivo
115. Seminalplasmin - An antimicrobial protein from bovine seminal plasma which acts in E. Coli by specific inhibition of rRNA synthesis
116. The antibacterial action of protamine: Evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium
117. Antimicrobial peptides and proteins in the innate defense of the airway surface
118. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid
119. Porcine epithelial beta-defensin 1 is expressed in the dorsal tongue at antimicrobial concentrations
120. Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model
121. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes
122. Cutting edge: Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein
123. Peptide antibiotics
124. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification
125. Peptide antibiotics
126. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds
127. Dot Far-Western blot analysis of relative binding affinities of the Src homology 3 domains of Efs and its related proteins
128. Cas
129. Proline-rich antimicrobial peptide, PR-39 gene transduction altered invasive activity and actin structure in human hepatocellular carcinoma cells
130. phox
131. +
132. PR-39, a proline/arginine-rich antimicrobial peptide, prevents post ischemic microvascular dysfunction
133. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice
134. Expression and biology of neutrophil and endothelial cell-derived chemokines
135. Chemokines: A new classification system and their role in immunity
136. Chemoattractant properties of PR-39, a neutrophil antibacterial peptide
137. LL-37, the neutrophils granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
138. PR39, a peptide regulator of angiogenesis
139. Protective effects of a novel 32-amino acid C-terminal fragment of CAP18 in endotoxemic pigs
140. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia
141. Activity of protegrins against yeast-phase Candida albicans
142. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37
143. Mode of action of linear amphipathic α-helical antimicrobial peptides
144. Cytotoxicity and apoptosis mediated by two peptides of innate immunity
145. Leukocytic antimicrobial peptides kill autoimmune T cells
146. Bactenecin, a leukocytic antimicrobial peptide, is cytotoxic to neuronal and glial cells
147. Apoptosis and the maintenance of homeostasis in the immune system
148. Using host defenses to fight infectious diseases
149. The therapeutic potential of cationic peptides
150. Cationic peptides: A new source of antibiotics
151. Gene-encoded peptide antibiotics and the concept of innate immunity: An update review
152. Antimicrobial peptides as mediators of epithelial host defense
153. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria
154. Porcine antimicrobial peptides: New prospects for ancient molecules of host defense